Marker Therapeutics Inc (MRKR)

[Marv79]

Thank you, good, it works for the bladder. Why doesn't Glynn Wilson or someone from TPIV communicate either formally or informally with the shareholders. I remember when AZN was getting much credit for this drug earlier in the year, stoch wen up 20%. I was very encouraged, however, TPIV share price went down not up. Now the drug fails lung and TPIV share price crashes. The CEO can not capitalize on good news and can not mitigate perceived bad news, can not inspire or execute. If he would have done his job a few years ago as he committed we be further down the road with more success able to push this aside today. He did not move fast enough, execute and now we are stuck losing more sleep. Now future good news keeps the share price from falling further not moving higher. Wilson needs to move on, a BioTech CEO needs to execute, be dynamic and move fast and Wilson did not (and can not) accomplish this over his long 13 year run at the company which cost the shareholders a bunch of money. And now one of the company's two primary collaborations may be in trouble and he will not communicate with the market or even informally with shareholders. He is burying his head in the sand again, can not get in trouble if you do not say anything or do anything. If this guy does not leave, we are going to lose more money!